Allarity Therapeutics, Inc. (ALLR) Form 8-K Material Events
Allarity Therapeutics, Inc. (ALLR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ALLR
CIK: 1860657
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Wolf & Company, P.C.
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerPiro Sassa
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-09 | 2026-01-22 | 4 Filing | 0001213900-26-108573 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-09-30 | CURRENT REPORT | 0001213900-26-105457 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-28 | CURRENT REPORT | 0001213900-26-104317 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-15 | CURRENT REPORT | 0001213900-26-100350 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-11 | CURRENT REPORT | 0001213900-26-099576 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | CURRENT REPORT | 0001213900-26-090183 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | FORM 10-Q | 0001437749-26-027830 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-06-26 | CURRENT REPORT | 0001213900-26-073998 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | CURRENT REPORT | 0001213900-26-070382 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-05-27 | CURRENT REPORT | 0001213900-26-064278 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | FORM 10-Q | 0001437749-26-017371 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-01-28 | OWNERSHIP DOCUMENT | 0001213900-26-056373 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-01-28 | OWNERSHIP DOCUMENT | 0001213900-26-054430 | View SEC Doc Filr Page |
| 3 | 2026-05-11 | 2025-06-10 | 3 Filing | 0001213900-26-054429 | View SEC Doc Filr Page |
| 8-K | 2026-05-08 | 2026-05-08 | CURRENT REPORT | 0001213900-26-054019 | View SEC Doc Filr Page |
| 4 | 2026-05-07 | 2026-01-28 | OWNERSHIP DOCUMENT | 0001213900-26-053466 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-05 | CURRENT REPORT | 0001213900-26-052542 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-050439 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | PROXY STATEMENT | 0001213900-26-050436 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-06-26 | PROXY STATEMENT | 0001213900-26-050231 | View SEC Doc Filr Page |
| 4/A | 2026-04-30 | 2026-01-28 | OWNERSHIP DOCUMENT | 0001213900-26-050133 | View SEC Doc Filr Page |
| 4 | 2026-04-30 | 2026-01-28 | OWNERSHIP DOCUMENT | 0001213900-26-050131 | View SEC Doc Filr Page |
| 8-K | 2026-04-28 | 2026-04-27 | CURRENT REPORT | 0001213900-26-048277 | View SEC Doc Filr Page |
| 424B3 | 2026-04-27 | — | PROSPECTUS | 0001213900-26-047735 | View SEC Doc Filr Page |
| EFFECT | 2026-04-24 | — | EFFECT Filing | 9999999995-26-001324 | View SEC Doc Filr Page |